Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($) |
Mar. 31, 2026 |
Dec. 31, 2025 |
||
|---|---|---|---|---|
| Schedule of Accrued Expenses and Other Current Liabilities [Abstract] | ||||
| Accrued research and development expense | [1] | $ 1,741,083 | $ 1,754,083 | |
| Accrued directors and officers (owners) compensation | 1,358,037 | 1,358,293 | ||
| Cash portion of the Lind Note repayments | 500,000 | 492,376 | ||
| Accrued compensation and employee benefits | 31,391 | 86,744 | ||
| Others | 523,853 | 470,133 | ||
| Total | $ 4,154,364 | $ 4,161,629 | ||
| ||||